Super Bowl, weight loss and Food and Drug Administration
Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and obesity, respectively.
The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
Weight-loss injections slash alcohol cravings and curb heavy drinking by almost half, new research revealed. The JAMA ...
WEIGHT loss jabs slash alcohol cravings and can curb dangerous binge drinking, new research suggests. The active drug ...
The research adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes. | ITV National News ...
Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback